Harel Insurance Investments & Financial Services Ltd. Incyte Corp Transaction History

Harel Insurance Investments & Financial Services Ltd.

  • $5.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023
BUY
$67.18 - $84.11 $34,060 - $42,643
507 Added 1.54%
33,471 $2.65 Million
Q3 2022

Oct 31, 2022
BUY
$66.18 - $82.86 $2.18 Million - $2.73 Million
32,964 New
32,964 $2.2 Million
Q1 2021

Apr 27, 2021
SELL
$76.02 - $100.5 $134,403 - $177,684
-1,768 Closed
0 $0
Q3 2020

Oct 20, 2020
BUY
$85.07 - $109.69 $150,403 - $193,931
1,768 New
1,768 $159,000

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email